These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22681253)

  • 21. The Notch pathway regulates the bone gain induced by PTH anabolic signaling.
    Delgado-Calle J; McAndrews K; Wu G; Orr AL; Ferrari A; Tu X; Srinivasan V; Roodman GD; Ebetino FH; Boeckman RK; Bellido T
    FASEB J; 2022 Mar; 36(3):e22196. PubMed ID: 35137455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actions of Parathyroid Hormone Ligand Analogues in Humanized PTH1R Knockin Mice.
    Daley EJ; Yoon SH; Reyes M; Bruce M; Brooks DJ; Bouxsein M; Potts JT; Kronenberg HM; Wein MN; Lanske B; Jüppner H; Gardella TJ
    Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35460406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergent biological properties of arrestin pathway-selective biased agonism.
    Appleton KM; Luttrell LM
    J Recept Signal Transduct Res; 2013 Jun; 33(3):153-61. PubMed ID: 23448506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor.
    Delgado-Calle J; Tu X; Pacheco-Costa R; McAndrews K; Edwards R; Pellegrini GG; Kuhlenschmidt K; Olivos N; Robling A; Peacock M; Plotkin LI; Bellido T
    J Bone Miner Res; 2017 Mar; 32(3):522-535. PubMed ID: 27704638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of PTH1R signaling by an extracellular binding antibody.
    Sarkar K; Joedicke L; Westwood M; Burnley R; Wright M; McMillan D; Byrne B
    Vitam Horm; 2022; 120():109-132. PubMed ID: 35953107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous ligand recognition and structural transition of a human PTH receptor.
    Kobayashi K; Kawakami K; Kusakizako T; Miyauchi H; Tomita A; Kobayashi K; Shihoya W; Yamashita K; Nishizawa T; Kato HE; Inoue A; Nureki O
    Mol Cell; 2022 Sep; 82(18):3468-3483.e5. PubMed ID: 35932760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors.
    Gensure RC; Gardella TJ; Jüppner H
    Biochem Biophys Res Commun; 2005 Mar; 328(3):666-78. PubMed ID: 15694400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infrequent delivery of a long-acting PTH-Fc fusion protein has potent anabolic effects on cortical and cancellous bone.
    Kostenuik PJ; Ferrari S; Pierroz D; Bouxsein M; Morony S; Warmington KS; Adamu S; Geng Z; Grisanti M; Shalhoub V; Martin S; Biddlecome G; Shimamoto G; Boone T; Shen V; Lacey D
    J Bone Miner Res; 2007 Oct; 22(10):1534-47. PubMed ID: 17576164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
    Esbrit P; Alcaraz MJ
    Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production.
    Delgado-Calle J; Hancock B; Likine EF; Sato AY; McAndrews K; Sanudo C; Bruzzaniti A; Riancho JA; Tonra JR; Bellido T
    FASEB J; 2018 May; 32(5):2878-2890. PubMed ID: 29401593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agonist-specific regulation of parathyroid hormone (PTH) receptor type 2 activity: structural and functional analysis of PTH- and tuberoinfundibular peptide (TIP) 39-stimulated desensitization and internalization.
    Bisello A; Manen D; Pierroz DD; Usdin TB; Rizzoli R; Ferrari SL
    Mol Endocrinol; 2004 Jun; 18(6):1486-98. PubMed ID: 14988434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the receptor for parathyroid hormone and parathyroid hormone related protein induces apoptosis via the extrinsic and intrinsic signaling pathway.
    Müller M; Gagiannis S; Nawroth PP; Brune M; Schilling T
    Int J Mol Med; 2009 Sep; 24(3):373-80. PubMed ID: 19639230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor activity-modifying protein modulation of parathyroid hormone-1 receptor function and signaling.
    Avgoustou P; Jailani ABA; Desai AJ; Roberts DJ; Lilley ER; Stothard GW; Skerry TM; Richards GO
    Front Pharmacol; 2024; 15():1455231. PubMed ID: 39376604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-arrestin-dependent parathyroid hormone-stimulated extracellular signal-regulated kinase activation and parathyroid hormone type 1 receptor internalization.
    Sneddon WB; Friedman PA
    Endocrinology; 2007 Aug; 148(8):4073-9. PubMed ID: 17525124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Informatic deconvolution of biased GPCR signaling mechanisms from in vivo pharmacological experimentation.
    Maudsley S; Martin B; Janssens J; Etienne H; Jushaj A; van Gastel J; Willemsen A; Chen H; Gesty-Palmer D; Luttrell LM
    Methods; 2016 Jan; 92():51-63. PubMed ID: 25986936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of PTH1R signaling by an ECD binding antibody results in inhibition of β-arrestin 2 coupling.
    Sarkar K; Joedicke L; Westwood M; Burnley R; Wright M; McMillan D; Byrne B
    Sci Rep; 2019 Oct; 9(1):14432. PubMed ID: 31594997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anabolic action of parathyroid hormone regulated by the β2-adrenergic receptor.
    Hanyu R; Wehbi VL; Hayata T; Moriya S; Feinstein TN; Ezura Y; Nagao M; Saita Y; Hemmi H; Notomi T; Nakamoto T; Schipani E; Takeda S; Kaneko K; Kurosawa H; Karsenty G; Kronenberg HM; Vilardaga JP; Noda M
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7433-8. PubMed ID: 22538810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptors for PTH and PTHrP: their biological importance and functional properties.
    Mannstadt M; Jüppner H; Gardella TJ
    Am J Physiol; 1999 Nov; 277(5):F665-75. PubMed ID: 10564229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered Signaling and Desensitization Responses in PTH1R Mutants Associated with Eiken Syndrome.
    Portales-Castillo I; Dean T; Cheloha RW; Creemer BA; Vilardaga JP; Savransky S; Khatri A; Jüppner H; Gardella TJ
    Commun Biol; 2023 Jun; 6(1):599. PubMed ID: 37268817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications.
    Vilardaga JP; Clark LJ; White AD; Sutkeviciute I; Lee JY; Bahar I
    Endocr Rev; 2023 May; 44(3):474-491. PubMed ID: 36503956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.